DeepNewz Markets

Market

GSK Influenza Vaccine FDA Approval by End of 2024?

GlaxoSmithKline•CureVac

Resolution / Starting Odds

Yes • 50%

No • 50%

FDA official announcements

Story

GSK Secures Full Rights to Develop COVID-19 and Influenza Vaccines from CureVac

Jul 3, 2024, 06:30 AM

GlaxoSmithKline (GSK) has announced a new licensing agreement with CureVac, securing full rights to develop and manufacture COVID-19 and influenza vaccines. This strategic investment in vaccine platform technologies aims to enhance GSK's ability to match the best platform to each pathogen, ultimately helping to prevent illness in more people worldwide.

View original story

Similar markets

GSK mRNA COVID-19 vaccine FDA approval by end of 2024?

Yes • 50%

No • 50%

GSK mRNA flu vaccine launch by mid-2025?

Yes • 50%

No • 50%

Outcome of GSK's mRNA flu vaccine Phase 2 trial by end of Q3 2024?

Positive • 33%

Neutral • 33%

Negative • 33%

Moderna mRNA influenza vaccine FDA approval by mid-2024?

Yes • 50%

No • 50%

GSK's mRNA COVID-19 vaccine Phase 3 trial starts by end of 2024?

Yes • 50%

No • 50%

Will GSK receive FDA approval for CMG1A46 by end of 2026?

Yes • 50%

No • 50%

GSK mRNA flu vaccine market share by end of 2025?

<10% • 25%

10-20% • 25%

20-30% • 25%

>30% • 25%

Will Pfizer and BioNTech's COVID-19-Flu vaccine receive FDA approval for individuals aged 18-64 by the end of 2024?

Yes • 50%

No • 50%

Will Novavax's vaccines receive FDA approval by the end of 2025?

Yes • 50%

No • 50%

FDA lift clinical hold on Novavax COVID-19-influenza vaccine by March 31, 2025?

Yes • 50%

No • 50%

Will AstraZeneca's FluMist nasal spray receive approval in the EU by end of 2024?

Yes • 50%

No • 50%

Moderna's H5N1 vaccine receives FDA approval by end of 2025?

Yes • 50%

No • 50%

Market

Story

Similar markets

GSK mRNA COVID-19 vaccine FDA approval by end of 2024?

GSK mRNA flu vaccine launch by mid-2025?

Outcome of GSK's mRNA flu vaccine Phase 2 trial by end of Q3 2024?

Moderna mRNA influenza vaccine FDA approval by mid-2024?

GSK's mRNA COVID-19 vaccine Phase 3 trial starts by end of 2024?

Will GSK receive FDA approval for CMG1A46 by end of 2026?

GSK mRNA flu vaccine market share by end of 2025?

Will Pfizer and BioNTech's COVID-19-Flu vaccine receive FDA approval for individuals aged 18-64 by the end of 2024?

Will Novavax's vaccines receive FDA approval by the end of 2025?

FDA lift clinical hold on Novavax COVID-19-influenza vaccine by March 31, 2025?

Will AstraZeneca's FluMist nasal spray receive approval in the EU by end of 2024?

Moderna's H5N1 vaccine receives FDA approval by end of 2025?

GSK COVID-19 Vaccine FDA Approval by End of 2024?

GSK COVID-19 Vaccine Phase 3 Trials Start by Mid-2024?

First Major Market to Approve GSK COVID-19 Vaccine by End of 2024

GSK New COVID-19 Vaccine Sales in 2025

GSK COVID-19 Vaccine FDA Approval by End of 2024?

GSK COVID-19 Vaccine Phase 3 Trials Start by Mid-2024?

First Major Market to Approve GSK COVID-19 Vaccine by End of 2024

GSK New COVID-19 Vaccine Sales in 2025